Papers › leukemia › 6027999

Venetoclax for Chronic Lymphocytic Leukaemia Progressing after Ibrutinib: a Multicentre, Open-Label Phase 2 Trial

The Lancet. Oncology · 01-1-2018 · 6027999 on PMC →

376 citations FWCI 24.97 Chronic Lymphocytic Leukemia Research Trend

Citation data as of 2026-04-12 (OpenAlex).

Extracted findings

This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 6027999 is in the queue.

In the meantime: Browse leukemia papers → · Ask about this topic → · Explore the graph →